RCSI researcher awarded ERC Starting Grant to develop cure for lethal lung disease Innovative research uses ‘lung-in-a-dish’ drug testing platform

RCSI researcher Killian Hurley awarded ERC Starting Grant to conduct research into treatments for lethal lung condition, pulmonary fibrosis

By Danielle Norton November 22, 2022 Updated February 20, 2024 3 min read

RCSI researcher, Professor Killian Hurley, has been awarded a European Research Council (ERC) Starting Grant to conduct innovative research into treatments for the lethal lung condition, pulmonary fibrosis.

The project, called STAR-TEL, is one of 408 projects chosen out of almost 3,000 applications to receive ERC funding. A total value of €636 million has been awarded across all ERC Starting Grant projects.